Lyzorca (Pregabalin) Launched at Malaysian Medical Association (MMA) Congress 2024

3 May 2024

The Marketing Ethical team has successfully launched a new product; Lyzorca (Pregabalin) at the Malaysian Medical Association (MMA) Congress 2024, held at Avante Hotel, Petaling Jaya on 3 May 2024. The event, officiated by Dr. Israfil Merican Fazil Merican, Pharmaniaga Head of Medical Affairs, marks another milestone for the company’s product line, especially in the pain management range. We hope that the successful launch of this medicine will further solidify our commitment to advancing healthcare. Also present was, Dr. Azizan Abdul Aziz, President of the MMA.